Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Testing growth hormone deficiency in adults.
Gabellieri E, Chiovato L, Lage M, Castro AI, Casanueva FF. Gabellieri E, et al. Front Horm Res. 2010;38:139-144. doi: 10.1159/000318503. Epub 2010 Jul 5. Front Horm Res. 2010. PMID: 20616504 Review.
The gastric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intake.
Senin LL, Al-Massadi O, Folgueira C, Castelao C, Pardo M, Barja-Fernandez S, Roca-Rivada A, Amil M, Crujeiras AB, Garcia-Caballero T, Gabellieri E, Leis R, Dieguez C, Pagotto U, Casanueva FF, Seoane LM. Senin LL, et al. Among authors: gabellieri e. PLoS One. 2013 Nov 26;8(11):e80339. doi: 10.1371/journal.pone.0080339. eCollection 2013. PLoS One. 2013. PMID: 24303008 Free PMC article.
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study.
Napoli R, Nicolucci A, Larosa M, Rossi MC, Candido R; RESTORE‐G (Retrospective analysis on the therapeutic approaches after GLP‐1 RA treatment in type 2 diabetes patients) Study Group. Napoli R, et al. Diabetes Obes Metab. 2024 Sep;26(9):3576-3586. doi: 10.1111/dom.15697. Epub 2024 Jun 10. Diabetes Obes Metab. 2024. PMID: 38853712
Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study.
Candido R, Nicolucci A, Larosa M, Rossi MC, Napoli R; RESTORE-G (Retrospective analysis on the therapeutic approaches after GLP-1 RA treatment in type 2 diabetes patients) Study Group. Candido R, et al. Nutr Metab Cardiovasc Dis. 2024 Aug;34(8):1846-1853. doi: 10.1016/j.numecd.2024.03.023. Epub 2024 Mar 23. Nutr Metab Cardiovasc Dis. 2024. PMID: 38693036 Free article.
SARS-Cov-2 Infection: A New Risk Factor for Pituitary Apoplexy?
Ragni A, Bendotti G, Biamonte E, Cavigiolo B, Gabellieri E, Leporati P, Mollero ELM, Gallo M. Ragni A, et al. Among authors: gabellieri e. Endocr Metab Immune Disord Drug Targets. 2024 Apr 26. doi: 10.2174/0118715303315494240419060719. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38676521
75 results